Identity
Lemon Bottle is a commercial product name, not a verified single peptide.
Source-specific finding, not full clinical sign-off.
Peptide library
Your guide to this compound.


The regulator warning and distributor response conflict with injectable marketing. Neither establishes an authorized fat-loss injection; the exact product and intended external use must be distinguished.
Existing source snapshot critically reassessed.
Based on the selected source scope described in this profile, often an indexed abstract. Full methods and clinician sign-off remain pending; no systematic-review claim.
Editorial assessment · 2026-09-07
Swissmedic warning and distributor addendum, 2024.
Swissmedic warned about unauthorized injectable products. The distributor said original ampoules are external-use cosmetics, not injections.
The 2024 Swissmedic notice states that injectable Lemon Bottle is not authorized in Switzerland. This is a dated, jurisdiction-specific finding; the external-use cosmetic claim is separate.
Limited selected-source check, not an exhaustive review. Full methods, complete safety, exact formulation/route pharmacokinetics, stability and current jurisdictional authorization remain outstanding.
Lemon Bottle is a commercial product name, not a verified single peptide.
Read the source-specific findings; biological activity is not equivalent to a clinical treatment benefit.
Reports or marketing claims do not establish effectiveness or safety. Identity, formulation and claimed effects may need independent verification.
Source-specific finding, not full clinical sign-off.
Reports or marketing claims do not establish effectiveness or safety. Identity, formulation and claimed effects may need independent verification.
Lemon Bottle is a commercial product name, not a verified single peptide.
Source-specific finding, not full clinical sign-off.
Swissmedic warned about unauthorized injectable products. The distributor said original ampoules are external-use cosmetics, not injections.
Source-specific finding, not full clinical sign-off.
Tested samples had inconsistent undeclared contents; their authenticity was disputed. Do not generalize sample results to every package.
Source-specific finding, not full clinical sign-off.
Swissmedic warning, March 26 and June 25, 2024.
Catalog review date: Sep 7, 2026. This date alone does not establish independent clinical review.